Stroke with large vessel occlusion in the posterior circulation: IV thrombolysis plus thrombectomy versus IV thrombolysis alone.
Manuel CappellariValentina SaiaGiovanni PracucciIlaria CasettaEnrico FainardiFabrizio SallustioMaria RuggieroMichele RomoliLuigi SimonettiAndrea ZiniGuido Andrea LazzarottiGiovanni OrlandiStefano ValloneGuido BigliardiLeonardo RenieriPatrizia NenciniVittorio SemeraroGiovanni BoeroSandra BraccoRossana TassiDavide CastellanoAndrea NaldiFrancesco BiraschiEttore NicoliniBruno Del SetteLaura MalfattoLuca AllegrettiTiziana TassinariAgostino TessitoreLudovica FerraùAndrea SalettiAlessandro De VitoElvis LafeAnna CavalliniMauro BerguiGiovanni BoscoPaola FeracoValeria BignaminiNicolò MandruzzatoFederica VitDikran MardighianMauro MagoniSimone ComelliMaurizio MelisRoberto MenozziUmberto ScodittiGiacomo CesterFederica ViarioAlessandro SteccoThomas FleetwoodPietro FilauriSimona SaccoAndrea GiorgianniLucia Princiotta CariddiMariangela PianoCristina MottoIvan GallesioFederica SepeGiuseppe RomanoMaria Federica GrassoEmilio LozuponeAntonio FasanoAlessio ComaiErica FranchiniStefano BruniMauro SilvestriniLuigi ChiumaruloMarco PetruzzelliMarco PaviaPaolo InvernizziEdoardo PuglielliAlfonsina CasalenaAlessandro PedicelliGiovanni FrisulloPietro AmistàMonia RussoMassimiliano AllegrittiStefano CaproniSalvatore MangiaficoDanilo Toninull nullPublished in: Journal of thrombosis and thrombolysis (2023)
Efficacy and safety of mechanical thrombectomy (MT) for stroke with posterior circulation large vessel occlusion (LVO) is still under debate. We aimed to compare the outcomes of stroke patients with posterior circulation LVO treated with intravenous thrombolysis (IVT) (< 4.5 h after symptom onset) plus MT < 6 h after symptom onset with those treated with IVT alone (< 4.5 h after symptom onset). Patients enrolled in the Italian Registry of Endovascular Treatment in Acute Stroke (IRETAS) and in the Italian centers included in the SITS-ISTR were analysed. We identified 409 IRETAS patients treated with IVT plus MT and 384 SITS-ISTR patients treated with IVT alone. IVT plus MT was significantly associated with higher rate of sICH (ECASS II) compared with IVT alone (3.1 vs 1.9%; OR 3.984, 95% CI 1.014-15.815), while the two treatments did not differ significantly in 3-month mRS score ≤ 3 (64.3 vs 74.1%; OR 0.829, 95% CI 0.524-1.311). In 389 patients with isolated basilar artery (BA) occlusion, IVT plus MT was significantly associated with higher rate of any ICH compared with IVT alone (9.4 vs 7.4%; OR 4.131, 95% CI 1.215-14.040), while two treatments did not differ significantly in 3-month mRS score ≤ 3 and sICH per ECASS II definition. IVT plus MT was significantly associated with higher rate mRS score ≤ 2 (69.1 vs 52.1%; OR 2.692, 95% CI 1.064-6.811) and lower rate of death (13.8 vs 27.1%; OR 0.299, 95% CI 0.095-0.942) in patients with distal-segment BA occlusion, while two treatments did not differ significantly in 3-month mRS score ≤ 3 and sICH per ECASS II definition. IVT plus MT was significantly associated with lower rate of mRS score ≤ 3 (37.1 vs 53.3%; OR 0.137, 0.009-0.987), mRS score ≤ 1 (22.9 vs 53.3%; OR 0.066, 95% CI 0.006-0.764), mRS score ≤ 2 (34.3 vs 53.3%; OR 0.102, 95% CI 0.011-0.935), and higher rate of death (51.4 vs 40%; OR 16.244, 1.395-89.209) in patients with proximal-segment BA occlusion. Compared with IVT alone, IVT plus MT was significantly associated with higher rate of sICH per ECASS II definition in patients with stroke and posterior circulation LVO, while two treatment groups did not differ significantly in 3-month mRS score ≤ 3. IVT plus MT was associated with lower rate of mRS score ≤ 3 compared with IVT alone in patients with proximal-segment BA occlusion, whereas no significant difference was found between the two treatments in primary endpoints in patients isolated BA occlusion and in the other subgroups based on site occlusion.